Citius Pharmaceuticals, Inc. (CTXR) Revenue 2017–2022
Citius Pharmaceuticals, Inc. (CTXR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$90,000FY2022 · since FY2017: $50,000 → $90,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $90,000 | +0.0% |
| FY2021 | $90,000 | +0.0% |
| FY2020 | $90,000 | +0.0% |
| FY2019 | $90,000 | +20.0% |
| FY2018 | $75,000 | +50.0% |
| FY2017 | $50,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTXR financial trends
CTXR Net incomeCTXR Net marginCTXR Gross profitCTXR Gross marginCTXR Operating incomeCTXR Operating marginCTXR Operating cash flowCTXR Free cash flowCTXR Capital expendituresCTXR Return on equityCTXR Stock buybacksCTXR Dividends paidCTXR Total assetsCTXR Total liabilitiesCTXR Shareholders’ equityCTXR overview →